For context, semaglutide and tirzepatide typically see 4-7% discontinuation rates due to adverse events in their trials
Niacinamide: visually smooths the skins surface, reduces the visibility of pores, and strengthens the protective epidermal barrier
Rao X, Zhao S, Braunstein Z, Mao H, Razavi M, Duan L, et al
This provides the preservation signal without exceeding recovery capacity
Summary: GLP-1/GIP medications help reduce inflammation in metabolic organsnot autoimmune or pain-related inflammation They DO: lower CRP and related metabolic inflammatory/oxidative stress biomarkers, improve metabolic liver disease activity in steatohepatitis settings, improve cardiometabolic risk markers such as blood pressure improve kidney outcomes in high-risk CKD populations (semaglutide
What people usually mean by "timing" is tolerability choosing a day that leaves room for gastrointestinal effects